# Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction

> **NCT01167751** · PHASE3 · COMPLETED · sponsor: **Royan Institute** · enrollment: 90 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **BIOLOGICAL:** MNC
- **BIOLOGICAL:** AC 133
- **BIOLOGICAL:** Control

## Key facts

- **NCT ID:** NCT01167751
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2016-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167751, "Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01167751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*